in this issue
Regions :: Western Europe :: Germany
Saltigo increases price for pharma intermediate
8:46 AM MST | December 23, 2013 | Deepti Ramesh
Saltigo (Leverkusen, Germany), a wholly owned subsidiary of Lanxess, says it will increase its prices worldwide for some multicustomer products by up to 5%, effective 1 January 2014. Products affected include chloroformates, 1,2,4-triazole, toluidine derivatives, benzothiazole, and cross-linking agents. The price increase has been necessitated by a steady increase in raw material and energy costs, Saltigo says. The product 1,2,4-triazole is used in the chemical synthesis of active agricultural and pharmaceutical ingredients. The intermediate is an important...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee